Cite

    DiazGranados, C. A., Saway, W., Gouaux, J., Baron, M., Baker, J., Denis, M., Jordanov, E., Landolfi, V., & Yau, E. (2015). safety and immunogenicity of high-dose trivalent inactivated influenza vaccine in adults 50–64 years of age. Vaccine, 33(51), 7188–7193. http://access.bl.uk/ark:/81055/vdc_100029917281.0x00002f